FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 83 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $397,465,000 | -32.6% | 66,134 | -37.8% | 0.00% | -100.0% |
| Q3 2017 | $590,032,000 | +19.6% | 106,312 | 0.0% | 0.00% | – |
| Q2 2017 | $493,288,000 | -4.8% | 106,312 | +1.6% | 0.00% | -100.0% |
| Q1 2017 | $518,161,000 | +37777.3% | 104,679 | -15.1% | 0.00% | -50.0% |
| Q4 2016 | $1,368,000 | +20.8% | 123,235 | +0.9% | 0.00% | +100.0% |
| Q3 2016 | $1,132,000 | +20.2% | 122,176 | -17.7% | 0.00% | 0.0% |
| Q2 2016 | $942,000 | -3.0% | 148,377 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $971,000 | +21.5% | 148,891 | +51.1% | 0.00% | 0.0% |
| Q4 2015 | $799,000 | -68.2% | 98,558 | -71.3% | 0.00% | -66.7% |
| Q3 2015 | $2,513,000 | -14.3% | 342,857 | +19.8% | 0.00% | 0.0% |
| Q2 2015 | $2,934,000 | – | 286,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |